endothelial dysfunction [dsyn]
Objective [inpr]
Benign condition [fndg]
Characterized [acty]
Unconjugated hyperbilirubinaemia [dsyn]
Decreased Activity [sosy]
Hepatic [blor]
symptoms [ftcn]
signs [ftcn]
Hemolysis [patf]
Present [qnco]
Study [mnob]
Circulating [ftcn]
asymmetric dimethylarginine [aapp, phsu]
pentraxin 3 [aapp, bacs]
High sensitivity [lbpr]
C-reactive protein [aapp, imft]
Patients [podg]
Correlation [qlco]
Unconjugated bilirubin [bacs, orch]
Levels [qlco]
molecules [sbst]
Prognostic Factor [clna]
vascular [bpoc]
Stratification [resa]
endothelial dysfunction [dsyn]
Methods [inpr]
Patients [podg]
Age [orga]
Sex [orgf]
matched [resa]
Subject [grup]
Study [mnob]
Make [ftcn]
Unconjugated hyperbilirubinaemia [dsyn]
mg dl [qnco]
mU/L [qnco]
Mole [neop]
Occasional [tmco]
Normal Values [qnco]
Liver Function Tests [lbpr]
Normal [qlco]
Hepatic [blor]
Imaging [diap]
absence [qnco]
Hemolysis [patf]
asymmetric dimethylarginine [aapp, phsu]
pentraxin 3 [aapp, bacs]
High sensitivity [lbpr]
C-reactive protein level [lbpr]
Healthy Control [qlco]
P NOS [aapp, imft]
P NOS [aapp, imft]
P NOS [aapp, imft]
Correlation [qlco]
Unconjugated bilirubin [bacs, orch]
Correlated [qlco]
asymmetric dimethylarginine [aapp, phsu]
pentraxin 3 [aapp, bacs]
High sensitivity [lbpr]
C-reactive protein [aapp, imft]
R- [spco]
P NOS [aapp, imft]
R- [spco]
P NOS [aapp, imft]
0.012" [qnco]
R- [spco]
P NOS [aapp, imft]
Discussion [topp]
Present [qnco]
Study [mnob]
Decreased [qnco]
Levels [qlco]
asymmetric dimethylarginine [aapp, phsu]
pentraxin 3 [aapp, bacs]
High sensitivity [lbpr]
C-reactive protein [aapp, imft]
effects [qlco]
Hyperbilirubinaemia [dsyn]
endothelial dysfunction [dsyn]
